Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Corcept Therapeutics Ownership Summary

Corcept Therapeutics is owned by 84.27% institutional investors, 11.52% insiders, and 4.21% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.74% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Corcept Therapeutics	84.27%	11.52%	4.21%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	16.54M	16.09%	$537.36M
Vanguard group	9.55M	9.29%	$310.40M
Renaissance	6.91M	6.72%	$224.59M
Parallel advisors	3.82M	3.71%	$123.97M
State street	3.50M	3.40%	$113.69M
Dimensional fund advisors lp	2.68M	2.60%	$86.95M
Novo	2.41M	2.35%	$78.35M
Geode capital management	2.28M	2.22%	$74.07M
Boston trust walden	1.58M	1.54%	$51.46M
First trust advisors lp	1.52M	1.48%	$49.44M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tanaka capital management	100.28K	7.71%	$3.26M
Novo	2.41M	3.93%	$78.35M
Parallel advisors	3.82M	3.18%	$123.97M
Birchview capital, lp	74.00K	2.23%	$2.40M
S&t bank/pa	199.79K	1.65%	$6.49M
Hussman strategic advisors	105.00K	0.94%	$3.41M
Fas wealth partners	315.77K	0.89%	$10.26M
Bridge city capital	49.24K	0.54%	$1.60M
Intrinsic edge capital management	181.02K	0.53%	$5.88M
Burney co/	416.80K	0.52%	$13.54M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	822.12K	0.00%	822.12K
Abrdn	524.64K	0.03%	524.64K
Fmr	1.09M	0.00%	242.50K
Intrinsic edge capital management	181.02K	0.53%	181.02K
Connor, clark & lunn investment management	716.06K	0.10%	173.88K

Top Sellers

Holder	Shares	% Assets	Change
Ikarian capital	-	-	-994.50K
Man group	829.94K	0.07%	-668.98K
Kynam capital management, lp	-	-	-585.90K
Bank of america corp /de/	174.85K	0.00%	-498.50K
Two sigma investments, lp	393.78K	0.03%	-424.69K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	822.12K	0.00%	822.12K	$26.71M
Abrdn	524.64K	0.03%	524.64K	$17.05M
Shelton capital management	140.49K	0.12%	140.49K	$4.56M
Lisanti capital growth	62.99K	0.49%	62.99K	$2.05M
Corebridge financial	47.36K	0.01%	47.36K	$1.54M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-16.00
Innealta capital	-33.00
Harbor investment advisory	-82.00
Newedge advisors	-562.00
Chiron investment management	-2.38K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	335	11.67%	87,110,973	-2.41%	84	1.12%	174	20.00%	101	-11.40%
Jun 30, 2024	295	-4.53%	89,230,600	-3.86%	86	1.06%	141	-16.07%	113	28.41%
Mar 31, 2024	309	7.29%	92,808,650	9.52%	90	1.35%	168	19.15%	88	-7.37%
Dec 31, 2023	288	12.50%	84,743,888	2.02%	81	1.23%	141	15.57%	95	3.26%
Sep 30, 2023	256	9.87%	83,063,010	1.82%	81	1.42%	122	37.08%	92	-5.15%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	6.02M	5.74%	2.66K
Vanguard Total Stock Mkt Idx Inv	2.81M	2.68%	-14.35K
iShares Russell 2000 ETF	2.24M	2.14%	-4.68K
Vanguard Small Cap Index	2.23M	2.13%	4.35K
Vanguard Institutional Extnd Mkt Idx Tr	1.38M	1.32%	-5.10K
Vanguard Small Cap Growth Index Inv	1.22M	1.17%	-1.68K
First Trust NYSE Arca Biotech ETF	859.92K	0.82%	-
SPDR® Portfolio S&P 600™ Sm Cap ETF	848.24K	0.81%	624.00
Fidelity Small Cap Index	822.01K	0.78%	-5.30K
iShares Russell 2000 Growth ETF	731.96K	0.70%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 10, 2024	Swisher Daniel N JR	-	Sell	$130.81K
Nov 22, 2024	Robb Gary Charles	Chief Business Officer	Sell	$146.63K
Nov 22, 2024	Lyon Joseph Douglas	See Remarks	Sell	$80.03K
Nov 11, 2024	Swisher Daniel N JR	-	Sell	$131.74K
Nov 04, 2024	Guyer William	Chief Development Officer	Sell	$166.20K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	7
2024 Q3	-	8
2024 Q2	-	12
2024 Q1	-	8
2023 Q4	-	17

CORT Ownership FAQ

Who Owns Corcept Therapeutics?

Corcept Therapeutics shareholders are primarily institutional investors at 84.27%, followed by 11.52% insiders and 4.21% retail investors. The average institutional ownership in Corcept Therapeutics's industry, Biotech Stocks , is 47.04%, which Corcept Therapeutics exceeds.

Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Vanguard group (9.55M shares, 9.29%), and Renaissance (6.91M shares, 6.72%). Together, they hold 32.11% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Tanaka capital management is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.71% of its assets in 100.28K Corcept Therapeutics shares, valued at 3.26M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.74% of its total shares outstanding invested in 6.02M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools